Boditech Med Inc.
KOE: 206640.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- ByeongCheol Kim
- Employees
- 469
- Headquarters
- Chuncheon-si, South Korea
- IPO year
- 2015
- Market cap
- ₩247.9B
- Website
- http://www.boditech.co.kr
Loading 206640…
Loading profile data…Frequently asked questions about 206640
What does Boditech Med Inc. (206640.KQ) do?
Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. It offers ichroma II, an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative, or semi-quantitative ways; automated fluorescent immunoassay systems under...
Where does 206640.KQ trade?
Boditech Med Inc. (206640.KQ) trades on the KOSDAQ.
What sector is 206640.KQ in?
Boditech Med Inc. (206640.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Boditech Med Inc.?
ByeongCheol Kim is the chief executive officer of Boditech Med Inc. (206640.KQ).
Where is Boditech Med Inc. headquartered?
Boditech Med Inc. is headquartered in South Korea.
Does 206640.KQ pay a dividend?
Yes — Boditech Med Inc. (206640.KQ) paid a trailing twelve-month dividend of KRW 150.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 206640.KQ go public?
Boditech Med Inc. (206640.KQ) completed its initial public offering in 2015.